Skip to main content
DOCHealthpeak Properties, Inc.Sell5.7·$18.55
SellModerate Confidence
Investment thesis

Healthpeak Properties has exceeded its analyst consensus target, leaving no positive asymmetry at current levels; while the portfolio demonstrates strong cash conversion and a high financial health score, heavy geographic concentration in San Francisco laboratory space and a dividend whose safety is in question make this a name to reduce rather than add.

Thesis pillars

  • Sf Lab Portfolio Concentration↓Deteriorating
  • Price Above Analyst Target→Stable
  • Dividend Safety Concern↑Improving
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 3, 2026

Full reasoning →

Open full analysis

Healthpeak Properties, Inc. (DOC) Stock Analysis

SellGrowthModerate Confidence

Real Estate · REIT - Healthcare Facilities

Earnings in 4 days (2026-11-02). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Momentum 3.4/10 is below the 5.0 floor at $18.55 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Thin upside margin: 8.7%; Concentration risk — Geographic: San Francisco lab portfolio (59.0%).

Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145 buildings), and senior housing (34 communities) segments in the U.S. Revenue comes from leases to healthcare providers, biotech tenants, and RIDEA-structured... Read more

$18.55+8.7% A.UpsideScore 5.7/10#9 of 15 REIT - Healthcare Facilities
QualityF-score8 / 9FCF yield12.51%
IncomeYield6.41%(5y avg 5.46%)Payout348.58%
Stop $17.70Analyst target $20.16(−10% haircut)A.R:R 1.7:1
Analyst consensus$22.39+20.7%19 analysts
$20.16Analyst target
$18.55price
$22.39mean
$17
$29

Sell if holding. Momentum 3.4/10 is below the 5.0 floor at $18.55 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Thin upside margin: 8.7%; Concentration risk — Geographic: San Francisco lab portfolio (59.0%). Chart setup: No clear chart pattern; technical signals are mixed. Score 5.7/10, moderate confidence.

Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and earnings proximity 4d<=7d. Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Nov 2, 20264d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Strong growth profile
Risks
Concentration risk — Geographic: San Francisco lab portfolio (59.0%)
Thin upside margin: 8.7%
Sector modifier (Real Estate): -1.2

Key Metrics

P/E (TTM)53.0
P/E (Fwd)132.5
Mkt Cap$13.2B
EV/EBITDA14.7
Profit Mgn8.2%
ROE3.0%
Rev Growth11.1%
Beta0.99
Dividend6.41%
Rating analysts26

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.60bullish
IV58%elevated
Max Pain$13-32.6% vs spot

Concentration Risks(10-K Item 1A)

  • LOWTenantHCA Healthcare7.0%
    10-K Item 1: 'most significant outpatient medical tenant concentration ... HCA Healthcare, Inc. (HCA)| | 15 | %| | 7 | %'
  • HIGHGeographicSan Francisco lab portfolio59%
    10-K Item 1: 'including San Francisco, California (59%), Boston, Massachusetts (22%), and San Diego, California (17%) (based on total square feet)'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Obv
1.0
Volume
1.7
Ma Position
2.2
Rsi
4.5
Macd
7.5
Volume distribution (falling OBV)Below 200-MA but MA still rising (+3.0%/30d) — pullback in uptrend, not confirmed weakness

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
4.0
Quality Rank
4.3
Value Rank
5.2
GatesMomentum 3.4<4.5EARNINGS PROXIMITY 4d<=7dA.R:R 1.7 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
52 · Neutral
↓ 20D MA↓ 50D MA↓ 200D MAGOLDEN CROSSSupport $18.25Resistance $19.78

Price Targets

$18
$20
A.Upside+8.7%
A.R:R1.7:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! momentum at 3.4 (below the engine's 4.5 threshold)
! EARNINGS_PROXIMITY:4d<=7d

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-02 (4d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is DOC stock a buy right now?

Sell if holding. Momentum 3.4/10 is below the 5.0 floor at $18.55 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Thin upside margin: 8.7%; Concentration risk — Geographic: San Francisco lab portfolio (59.0%). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $17.70. Score 5.7/10, moderate confidence.

What is the DOC stock price target?

Analyst target: $20.16 (+8.7% upside). Prior stop was $17.70. Stop-loss: $17.70.

What are the risks of investing in DOC?

Concentration risk — Geographic: San Francisco lab portfolio (59.0%); Thin upside margin: 8.7%; Sector modifier (Real Estate): -1.2.

Is DOC overvalued or undervalued?

Healthpeak Properties, Inc. trades at a P/E of 53.0 (forward 132.5). TrendMatrix value score: 6.1/10. Verdict: Sell.

What do analysts say about DOC?

26 analysts cover DOC with a consensus score of 3.5/5. Average price target: $22.

What does Healthpeak Properties, Inc. do?Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145...

Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145 buildings), and senior housing (34 communities) segments in the U.S. Revenue comes from leases to healthcare providers, biotech tenants, and RIDEA-structured senior housing operators; 2025 Adjusted NOI: outpatient medical $796M, lab $567M, senior housing $177M.

Related stocks: LTC (LTC Properties, Inc.) · NHI (National Health Investors, Inc.) · OHI (Omega Healthcare Investors, Inc) · CTRE (CareTrust REIT, Inc.) · AHR (American Healthcare REIT, Inc.)
Home › Stocks › DOC

Latest news

Latest News

MarketWatch92d ago
TradingView92d agoEarnings
TradingView85d ago
Yahoo Finance85d ago
Investing.com South Africa85d ago
MarketWatch93d ago
Investing.com South Africa93d ago
Investing.com93d ago
MarketBeat93d agoEarnings
Seeking Alpha93d ago
GuruFocus184d agoAnalyst
MarketBeat184d ago
MarketBeat184d agoAnalyst
Seeking Alpha177d ago
MarketBeat86d agoEarnings
TipRanks86d ago
Seeking Alpha86d ago
GuruFocus86d agoEarnings
Marketscreener.com86d agoEarnings
Marketscreener.com86d agoEarnings
Loading more...